 |
 |
Next week, I am due to start a course of tablets of a new drug called REMACEMIDE. This is one of those early tests where they are trying to determine the maximum safe dose, the minimun effective dose, and to get a feel for the possibility of unwanted side-effects. The drug, (if it works) seems to be a complete break from the Dopamine agonist type of drug: I think the best description (from the little that I have gleaned,) is that Remecemide operates on the globus pallidus, and may produce a 'Chemical Pallidotomy' effect on the patient (Returning to normal when you stop taking the tablets.) The reason for me writing is that I was told that these trials are part of a joint study which is being carried out in the UK And the USA. Is anyone out there taking part in the same trials? If so, I would like to hear from you. Regards, -- Brian Collins <[log in to unmask]>